Microarray Company OGT Now Offering Targeted Sequencing Services | GenomeWeb

By Monica Heger

Microarray company Oxford Gene Technologies is moving into the next-gen sequencing space, offering targeted capture and sequencing services on Illumina's HiSeq, Life Technologies' SOLiD, and Roche's 454 GS FLX.

OGT does not currently own any sequencing machines, but is looking to purchase one by the end of the year. For the time being, it is contracting out its sequencing to academic and commercial partners while doing the capture and bioinformatics in house.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.